Alzprotect
Latest round
- Series B
Last raised
- Jan 2018
Total raised
- $4.2M
Investors
- 4
About Alzprotect
Founded in 2007, Alzprotect SAS is headquartered in Loos, France. The company specializes in creating therapeutic solutions for neurodegenerative diseases through innovative approaches.921 mn.Alzprotect specializes in developing therapeutic solutions for neurodegenerative diseases, focusing on tauopathies like PSP and Alzheimer’s disease. Their primary product, AZP2006, aims to halt neurodegeneration and restore brain functions by targeting markers associated with neurodegenerative diseases.Alzprotect generates revenue through partnerships and collaborations in the biopharmaceutical sector, particularly in clinical trials and research agreements. The company aims to expand its market presence in Europe, North America, and Asia by establishing new partnerships and collaborations by the end of 2025.
Who invested in Alzprotect
4 investors across 1 round
See all investors in Alzprotect
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 31, 2018
Amount
$4.2M
Investors
Questions about Alzprotect
Who invested in Alzprotect?
Alzprotect has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alzprotect raised?
Alzprotect has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Alzprotect last raise money?
Alzprotect's most recent round on record is a Series B, in Jan 2018.
What does Alzprotect do?
Founded in 2007, Alzprotect SAS is headquartered in Loos, France.
Where is Alzprotect headquartered?
Alzprotect is headquartered in Loos, France.
Which VCs invest in companies like Alzprotect?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Alzprotect's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Alzprotect? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.